Clinical Trial Update: Efficacy, Safety, PK, PD, and ADA of Eculizumab in Chinese Adults With NMOSD [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy, safety, pharmacokinetics, pharmacodynamics, and anti-drug antibodies of eculizumab in Chinese adults with neurom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromyelitis Optica Spectrum Disorders

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: NMOSD, Neuromyelitis Optica Spectrum Disorders | Phase 3 | Status: ACTIVE_NOT_RECRUITING